跳至主要内容
临床试验/NCT02922244
NCT02922244已完成不适用

Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients

Chulabhorn Cancer Center2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
2
主要终点
Change of dermatitis grading

研究概览

简要总结

The herbal products on reduction of radiation-induced dermatitis in patients with breast cancer

详细描述

To compare the effect of each herb extracts to protect the skin from the adverse effects of radiation therapy in patients with breast cancer with herbal extract products.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 20 years old or older,
  • Diagnosed with Breast cancer
  • On course of external Radiation therapy

排除标准

  • Previously underwent external Radiation therapy
  • Illiterate

结局指标

主要结局

Change of dermatitis grading

时间窗: Change from baseline dermatitis grading at 1, 2, 3, 4, 5 weeks and at 9 week.

RTOG (Radiation Therapy Oncology Group) Cooperative Group Common Toxicity Criteria Skin Grade 0:None or no change Grade 1:Scattered macular or papular eruption or erythema that is asymptomatic Grade 2:Scattered macular or papular eruption or erythema with pruritis or other associated symptoms Grade 3:Generalized symptomatic macular, papular, or vesicular eruption Grade 4:Exfoliative dermatitis or ulcerating dermatitis Grade 5:If that toxicity caused the death of the patient.

次要结局

  • Patient satisfaction with the cream(At 9 week from date of randomization)

研究者

发起方
Chulabhorn Cancer Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Saengrawee Thanthong

Principal Investigator

Chulabhorn Cancer Center

研究点 (2)

Loading locations...

相似试验